Varying Combinations Of Antiviral Drugs May Effectively Treat Chronic Hepatitis Virus Infection In Woodchucks And Have Implications For Use In Humans Oral administration of various combined and independent antiviral drug therapies may effectively treat chronic hepatitis B virus (HBV) infection in woodchucks, a well-characterized mammalian model for research with human implications, and provide an alternative strategy for managing drug resistance.
Source: www.medicalnewstoday.comIf Rats Consume A Lot Of Fructose, And Have A High-calorie, High-fat Diet, They Become Overweight Eating too much fructose can induce leptin resistance, a condition that can easily lead to becoming overweight when combined with a high-fat, high-calorie diet, according to a new study with rats.
Source: www.medicalnewstoday.comKenyan Health Officials Announce New Rules For Pediatric HIV/AIDS Testing Kenya's Ministry of
Health on Monday announced changes to its HIV testing and treatment procedures for at-risk infants and children in the country, The Nation/AllAfrica.com reports. The recommendations came in the form of a circular, titled "Change on Pediatric ART recommendations; Early Initiation of ART in infants," which was distributed on Sept.
Source: www.medicalnewstoday.comHealthcare Commission Needs To Raise The Bar For Mental Health Service Users, UK Commenting on the Annual
Health check, Lisa Rodrigues, Chair of the Mental
Health Network of the NHS Confederation, and Chief Executive of Sussex Partnership NHS Foundation Trust said: "This is the second year running that NHS mental
health trusts have been rated as one of the best performing pa
Source: www.medicalnewstoday.comSAMHSA Awards More Than $12 Million To Help Community Programs Meet The Mental Health Needs Of Older Americans The Substance Abuse and Mental
Health Services Administration (SAMHSA) today announced the award of 10 grants totaling more than $12 million over three years through the Older Adults Targeted Capacity Expansion Grant Program to help communities meet the special mental
health needs of older Americans.
Source: www.medicalnewstoday.comZIOPHARM Receives Orphan Medicinal Product Designation For Palifosfamide (ZIO-201) In The Treatment Of Soft Tissue Sarcoma ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP), announced today that the European
Medicines Agency's (EMEA) Committee for Orphan Medicinal Products (COMP) has issued a positive opinion regarding ZIOPHARM's application for orphan medicinal product designation for palifosfamide in the treatment of soft tissue sarcoma (STS).
Source: www.medicalnewstoday.com
# posted by Network @ 9:00 PM
